Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 12, 2018
Patent Application Number
14161660
Date Filed
January 22, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed are synthetic nanocarrier methods, and related compositions, comprising B cell and/or MHC Class II-restricted epitopes and immunosuppressants in order to generate tolerogenic immune responses, such as the generation of antigen-specific regulatory B cells.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
